New Adverse Drug Reaction Signals from 2017 to 2021—Genuine Alerts or False Alarms? by Yoon Kong Loke, Katharina Mattishent, Navena Navaneetharaja

Subjects: Get full text

Drug-associated congenital anomalies of the external ear identified in the United States food and drug administration adverse event reporting system database by Xinyu Li, Jiajia Hao, Datao Li, Ruhong Zhang

Subjects: Get full text

Disproportionality analysis of drug-induced dry mouth using data from the United States food and drug administration adverse event reporting system database by Dan Xu, Hong Zhu, Meng Wu

Subjects: Get full text

A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS) by Ning Wang, Haijun Wang, Ying Chen, Yanfeng Wang

Subjects: Get full text

Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data by Kaidi Zhao, Yang Zhao, Shengxiang Xiao, Chen Tu

Subjects: Get full text

A disproportionality analysis of FDA adverse event reporting system events for misoprostol by Li Yang, Wenting Xu

Subjects: Get full text

Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database by Wen-Long Xie, Meng-Lan Ge, Dan Chen, Guo-Qing Chen, Yuan-Xi Mei, Yong-Ji Lai

Subjects: Get full text

Disproportionality analysis of quinolone safety in children using data from the FDA adverse event reporting system (FAERS) by Wenqiang Kong, Wei Mao, Lin Zhang, Yanyan Wu, Yanyan Wu

Subjects: Get full text

Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Dat... by Danyi Liu, Junting Liu, Rui Xiao, Anqi Deng, Wei Liu

Subjects: Get full text

Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004–2023) by Lin Chen, Zhicheng Dai, Huangrong Song, Jiafeng Zhang, Tuo Li

Subjects: Get full text

Signal mining and analysis of ripretinib adverse events: a real-world pharmacovigilance analysis based on the FAERS database by Ye Hu, Linlin Zhang, Qineng Gong, Lei Huang, Cunlin Yin, Yang Miao, Hui Wu

Subjects: Get full text

A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system by Ke He, Kaidi Zhao, Tingyi Yin, Meng Liu, Jiashu Liu, Wenqian Du, Xinyi Liu, Baochen Cheng, Dewu Zhang, Yan Zheng

Subjects: Get full text

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system by Zhiyuan Zhang, Zhiyuan Zhang, Yifan Yao, Li Zhu, Li Zhu

Subjects: Get full text

Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration by Jing Zhang, Xiaofen Wang, Yiting Zhou

Subjects: Get full text

Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database by Fang Wu, Fang Wu, Siliang Wang, Siliang Wang, Xihui Xu, Weihui Zhang, Weihui Zhang, Jie Zhou, Jie Zhou, Runyan Niu, Runyan Niu, Wenting Cai, Wenting Cai, Yonggong Yang, Mengying Liu, Mengying Liu, Jinping Zhang, Jinping Zhang

Subjects: Get full text

Conducting a real-world study of Tumor Necrosis factor-alpha inhibitors-induced Systemic Lupus Erythematosus based on the FAERS database by Mengjiao He, Jiale Yang, Simin Yan, Qing Shu, Peng Cheng Liu

Subjects: Get full text

Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database by Yi Zheng, Xiaojing Guo, Chenxin Chen, Lijie Chi, Zhijian Guo, Jizhou Liang, Lianhui Wei, Xiao Chen, Xiaofei Ye, Jia He

Subjects: Get full text

A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system by Lisha Wu, Lisha Wu, Maosheng Xu, Xueqin Li, Dilinuer Aierken, Jinxiu Yu, Tao Qin, Tao Qin

Subjects: Get full text

A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for alpelisib by Yu Lin, Xinlei Zheng, Yan Chen, Qichun Nian, Li Lin, Maohua Chen

Subjects: Get full text

Adverse Event Profiles of Adalimumab in Children: A Disproportionality Analysis by Wenting Zhang, Ziqi Xu, Yamin Shu, Sainan Shu, Qilin Zhang

Subjects: Get full text